NASDAQ: WAY · Healthcare Information Services
Waystar Holding (WAY) fair value: undervalued or overvalued?
As of 14 Nov 2026, Faircurve's model values Waystar Holding (WAY) at $30.05 a share. The stock last closed at $28.11, which puts the model's fair value 6.9% above the price. On the model's bands that reads as Fairly valued.
Revalued . Price is the close of 16 Nov 2026. Waystar Holding Corp.
The report adds the live price, the chart against the range the options market prices, the next earnings date and the analysts' consensus. No account needed.
This week, in three parts
What happenedThe run of 14 Nov 2026 moved the fair value from $30.83 to $30.05 (-2.5%). The companies the model compares it with now trade on lower multiples: most of the move.
What the model makes of itThe price of $28.11 is 6.9% below it: Fairly valued, on a high evidence grade.
What's nextNext report on 16 Feb 2027. Options prices imply a move of about 17% either way over the next month. The next weekly run is on Saturday 21 Nov 2026.
What price range does the model give WAY?
The calibrated range for WAY over 63 trading days is $23.04 to $34.64. It sits around the last close, and its width comes from the volatility that WAY's own options imply (60% a year), calibrated weekly against realised prices (n = 8,038 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon. The fair value is the model's opinion and rides beside the range. It is not the centre of it.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $23.95 to $37.00. In 60% of the simulations the fair value came out above the price the model ran on.
Faircurve Insights · 14 Nov 2026
Waystar Holding Corp. (WAY) develops a cloud-based software platform designed to streamline financial transactions within the healthcare industry.
Faircurve's model put the fair value of Waystar at $30.05 a share on 14 Nov 2026, the midpoint of 2,000 simulations. That is down from $30.83 on the previous run, on 7 Nov 2026, a move of -2.5%. In the model's own words, "The companies the model compares it with now trade on lower multiples: most of the move." The calibrated range over 63 trading days is $23.04 to $34.64, built around the price from the volatility the stock's own options imply. Ranges built this way held the price 60% of the time at this horizon, across 8,038 past valuations. The model grades the evidence High. That grade reflects how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It does not say whether the fair value is right.
Waystar scores 52 out of 100 on the model's overall quality measure, a composite of six factors scored against comparable companies. Growth quality stands out at 85, with trailing revenue growth of 16.5% against a peer median of 6.9%. Capital discipline and the balance sheet each score 17. Net debt to EBITDA is 3.28x, against a peer median of 0.97x. The model compares Waystar with Doximity, Inc. (DOCS), Privia Health Group, Inc. (PRVA), Certara, Inc. (CERT), Omnicell, Inc. (OMCL) and HealthStream, Inc. (HSTM).
Written from the figures on this page for the 14 Nov 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
The Global Pulse
Faircurve's note after each US session, in your inbox. No account needed.
When does WAY report earnings, and how has the stock reacted?
Waystar Holding's next earnings report is scheduled for 16 Feb 2027. Companies can move their dates.
Options prices on 16 Nov 2026 imply a move of about 14.0% in either direction through the nearest expiry, about 31 days out. That is the size the market is pricing, not a direction. WAY's 30 day implied volatility works out to about 17.4% over one month.
Around its last 8 reports: what the options market priced, and what followed
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across WAY's last 8 reports, ignoring direction, was 5.3%.
What the options market has priced for a month's move in WAY
How does WAY score on business quality?
Waystar Holding's overall quality score is 52 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 55 | 3.5%ROIC | 2.2% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 50 | 1.95xFCF / net income | 2.11x |
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analysts' rating changes. | 85 | 16.5%Revenue growth, trailing | 6.9% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 17 | 0.6%Net buybacks / market value | 3.5% |
| Balance sheetNet debt to EBITDA and interest coverage. | 17 | 3.28xNet debt / EBITDA | 0.97x |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 50 | 2.3 ptsEBITDA margin downside volatility, 5y | 4.1 pts |
How does WAY compare with similar companies?
The companies in healthcare information services closest to Waystar Holding in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| DOCS Doximity, Inc. | $32.77 | $32.13 | -2.0% | Fairly valued |
| HQY HealthEquity, Inc. | $104.58 | $104.84 | +0.2% | Low evidence grade |
| PRVA Privia Health Group, Inc. | $25.26 | $21.92 | -13.2% | Overvalued |
| BTSG BrightSpring Health Services, Inc. Common Stock | $71.37 | $68.74 | -3.7% | Low evidence grade |
| CERT Certara, Inc. | $11.39 | $11.49 | +0.9% | Fairly valued |
| OMCL Omnicell, Inc. | $35.44 | $37.58 | +6.0% | Fairly valued |
| HSTM HealthStream, Inc. | $27.68 | $27.45 | -0.8% | Fairly valued |
What the comparable companies' multiples alone would give for WAY, the peer-implied price, is $34.04 a share on this run. The fair value weighs that against the company's own multiple.
All healthcare information services stocks ranked by gap to fair value
Waystar Holding at a glance
Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry.
- Market value
- $5.4B
- Sector
- Healthcare
- Industry
- Healthcare Information Services
- Revenue expected, next twelve months
- $1.4B
- Consensus revenue growth, next fiscal year
- +16.7%
- Analysts with estimates
- 13
- Beta to the US market
- 0.51
- First valued by Faircurve
- 11 Jul 2026
At the close of 16 Nov 2026, 56.8% of the 1,085 graded US stocks the model covers traded below the model's fair value. WAY was among them.
How the fair value is worked out: the model prices Waystar Holding on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 7 Nov 2026 the model's fair value for WAY was $30.83. As of 14 Nov 2026 it is $30.05, a change of -2.5%. The companies the model compares it with now trade on lower multiples: most of the move. The model revalues every stock it covers each week, and again after an earnings report.
Questions about Waystar Holding's valuation
Is Waystar Holding stock undervalued or overvalued?
On Faircurve's model, WAY reads as Fairly valued as of 14 Nov 2026. The model's fair value is $30.05 a share against a last close of $28.11, a gap of +6.9%.
What is WAY's fair value?
$30.05 a share as of 14 Nov 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $23.95 to $37.00.
What price range does the model give WAY?
$23.04 to $34.64 over 63 trading days. Ranges built this way held the price 60% of the time across 8,038 past valuations, refreshed 14 Nov 2026.
When does Waystar Holding report earnings next?
The next report is scheduled for 16 Feb 2027. Companies can move their dates.
How much has WAY moved on past earnings reports?
Across its last 8 reports the median two session move was 5.3%, ignoring direction. The largest was -15.3% around the report of 29 Apr 2026.
How confident is the model in this valuation?
The model's evidence grade for WAY is high. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.
The model's own ideas on WAY
The model holds no idea open on WAY today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on WAY with their outcomes. A free account is enough.